Clinical Trial Update: An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the durability of immunity for an inactivated Enterovirus 71 vaccine (Vero cell) in Hand, Foot and Mouth Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Enterovirus 71 Inactivated Vaccine (Vero Cell) (Enterovirus 71 inactivated vaccine (Vero cell))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: UNKNOWN